JP2015502340A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015502340A5 JP2015502340A5 JP2014539044A JP2014539044A JP2015502340A5 JP 2015502340 A5 JP2015502340 A5 JP 2015502340A5 JP 2014539044 A JP2014539044 A JP 2014539044A JP 2014539044 A JP2014539044 A JP 2014539044A JP 2015502340 A5 JP2015502340 A5 JP 2015502340A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- variable region
- chain variable
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161552337P | 2011-10-27 | 2011-10-27 | |
| US61/552,337 | 2011-10-27 | ||
| PCT/US2012/062124 WO2013063395A1 (en) | 2011-10-27 | 2012-10-26 | Humanized antibodies to inkt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015502340A JP2015502340A (ja) | 2015-01-22 |
| JP2015502340A5 true JP2015502340A5 (https=) | 2015-12-17 |
Family
ID=48168549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014539044A Pending JP2015502340A (ja) | 2011-10-27 | 2012-10-26 | ｉＮＫＴに対するヒト化抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9932402B2 (https=) |
| EP (1) | EP2755688A4 (https=) |
| JP (1) | JP2015502340A (https=) |
| KR (1) | KR20140093964A (https=) |
| CN (1) | CN103945867B (https=) |
| AU (1) | AU2012328588C1 (https=) |
| BR (1) | BR112014009962A2 (https=) |
| CA (1) | CA2853719A1 (https=) |
| HK (2) | HK1199837A1 (https=) |
| IL (1) | IL232017A0 (https=) |
| RU (1) | RU2014120694A (https=) |
| SG (1) | SG11201401319XA (https=) |
| WO (1) | WO2013063395A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2970451A1 (en) * | 2013-03-14 | 2016-01-20 | Amgen Inc. | Chrdl-1 antigen binding proteins and methods of treatment |
| WO2015069697A2 (en) * | 2013-11-05 | 2015-05-14 | Nkt Therapeutics Inc. | Combination therapy |
| ES2866935T3 (es) * | 2014-01-10 | 2021-10-20 | Anaptysbio Inc | Anticuerpos dirigidos contra interleucina-33 (IL-33) |
| US20170182077A1 (en) * | 2014-02-14 | 2017-06-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of acute exacerbations of chronic obstructive pulmonary disease |
| TWI734975B (zh) * | 2014-06-27 | 2021-08-01 | 美商Ｃ２Ｎ醫療診斷有限責任公司 | 人類化抗-tau抗體 |
| WO2016013672A1 (ja) * | 2014-07-25 | 2016-01-28 | 国立研究開発法人理化学研究所 | メモリーインバリアントｎｋｔ細胞マーカー |
| US20160022777A1 (en) * | 2014-07-28 | 2016-01-28 | Nkt Therapeutics Inc. | Combination therapy with il-12 |
| US11933786B2 (en) | 2015-03-30 | 2024-03-19 | Stcube, Inc. | Antibodies specific to glycosylated PD-L1 and methods of use thereof |
| JP7003036B2 (ja) | 2015-12-02 | 2022-02-04 | エスティーキューブ，インコーポレイテッド | グリコシル化ｐｄ－１に対して特異的な抗体およびその使用方法 |
| CN109071636A (zh) | 2016-03-29 | 2018-12-21 | 斯特库比股份有限公司 | 用于选择特异性结合糖基化免疫检查点蛋白的抗体的方法 |
| EP3452510A4 (en) | 2016-04-04 | 2020-01-15 | Bioverativ USA Inc. | ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF |
| CN109715666B (zh) | 2016-07-20 | 2023-02-21 | 斯特库比股份有限公司 | 癌症治疗方法和使用结合糖基化pd-l1的抗体的组合的疗法 |
| CA3037144A1 (en) * | 2016-09-16 | 2018-03-22 | Shanghai Henlius Biotech, Inc. | Anti-pd-1 antibodies |
| WO2020156335A1 (zh) * | 2019-01-29 | 2020-08-06 | 上海交通大学 | 一种嵌合抗原受体及其应用 |
| EP4139350A4 (en) | 2020-04-20 | 2024-04-24 | Genzyme Corporation | Humanized anti-complement factor bb antibodies and uses thereof |
| JP2023522979A (ja) * | 2020-04-23 | 2023-06-01 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | ｉＮＫＴ細胞の活性化による老化細胞の排除 |
| EP4301374A4 (en) | 2021-03-01 | 2025-09-10 | Deciduous Therapeutics Inc | COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119248B1 (en) | 1994-04-12 | 2006-10-10 | Miltenyi Biotec Gmbh | Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof |
| WO1997016203A1 (en) | 1995-11-01 | 1997-05-09 | Genetics Institute, Inc. | Methods for administration of il-12 |
| AU2087799A (en) | 1997-12-31 | 1999-07-19 | Brigham And Women's Hospital | Diagnostic and therapeutic methods based upon valpha24jalphaq t cells |
| JP5184732B2 (ja) | 2000-06-19 | 2013-04-17 | ベス イスラエル デアコネス メディカル センター | Ｔ細胞亜集団に特異的なモノクローナル抗体およびポリクローナル抗体の組成物および使用方法 |
| WO2003007889A2 (en) * | 2001-07-17 | 2003-01-30 | Research Development Foundation | Therapeutic agents comprising pro-apoptotic proteins |
| ES2365210T3 (es) | 2002-06-14 | 2011-09-26 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health | Procedimientos de tratamiento y prevención de colitis en la que se implican la il-13 y los linfocitos t citolíticos naturales. |
| US9809654B2 (en) * | 2002-09-27 | 2017-11-07 | Vaccinex, Inc. | Targeted CD1d molecules |
| EP1784196B1 (en) | 2004-08-27 | 2016-12-21 | Albert Einstein College Of Medicine Of Yeshiva University | Ceramide derivatives as modulators of immunity and autoimmunity |
| WO2006060117A2 (en) * | 2004-11-02 | 2006-06-08 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for inhibition of nkt cells |
| PE20071101A1 (es) * | 2005-08-31 | 2007-12-21 | Amgen Inc | Polipeptidos y anticuerpos |
| WO2008140487A2 (en) * | 2006-11-14 | 2008-11-20 | Elusys Therapeutics, Inc. | Improved staphylococcal protein a mono- and bispecific antibodies and methods of their use |
| WO2008100912A1 (en) | 2007-02-12 | 2008-08-21 | The General Hospital Corporation | Methods for attenuating allergen-induced airway hyperreactivity using cd1d dependent antagonists |
| US8012484B2 (en) | 2007-04-12 | 2011-09-06 | University Of Virginia Patent Foundation | Method of treating ischemia reperfusion injury by inhibiting NKT cell activity |
| US20090028849A1 (en) | 2007-07-24 | 2009-01-29 | O'brien Rebecca L | Agents and methods for inhibition of airway hyperresponsiveness |
| US20110300154A1 (en) * | 2007-08-21 | 2011-12-08 | Children's Medical Center Corporation | Treatment of airway hyperreactivity |
| EP2586797A3 (en) * | 2007-11-27 | 2013-07-24 | Medtronic, Inc. | Humanized anti-amyloid beta antibodies |
| GB0902916D0 (en) * | 2009-02-20 | 2009-04-08 | Fusion Antibodies Ltd | Antibody therapy |
| WO2011112889A2 (en) | 2010-03-12 | 2011-09-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | β-MANNOSYLCERAMIDE AND STIMULATION OF NKT CELL ANTI-TUMOR IMMUNITY |
| WO2011149881A2 (en) | 2010-05-24 | 2011-12-01 | Children's Medical Center Corporation | Methods for the treatment and prevention of inflammatory diseases |
| PT2785683T (pt) | 2011-11-30 | 2020-04-16 | Ludwig Inst For Cancer Res Ltd | Moduladores de célula inkt e métodos para o seu uso |
| WO2015069697A2 (en) | 2013-11-05 | 2015-05-14 | Nkt Therapeutics Inc. | Combination therapy |
| US20160022777A1 (en) | 2014-07-28 | 2016-01-28 | Nkt Therapeutics Inc. | Combination therapy with il-12 |
-
2012
- 2012-10-26 JP JP2014539044A patent/JP2015502340A/ja active Pending
- 2012-10-26 CN CN201280053174.3A patent/CN103945867B/zh not_active Expired - Fee Related
- 2012-10-26 BR BR112014009962A patent/BR112014009962A2/pt not_active IP Right Cessation
- 2012-10-26 WO PCT/US2012/062124 patent/WO2013063395A1/en not_active Ceased
- 2012-10-26 HK HK15100381.0A patent/HK1199837A1/xx unknown
- 2012-10-26 AU AU2012328588A patent/AU2012328588C1/en not_active Ceased
- 2012-10-26 CA CA2853719A patent/CA2853719A1/en not_active Abandoned
- 2012-10-26 US US13/661,386 patent/US9932402B2/en not_active Expired - Fee Related
- 2012-10-26 EP EP12843689.6A patent/EP2755688A4/en not_active Withdrawn
- 2012-10-26 SG SG11201401319XA patent/SG11201401319XA/en unknown
- 2012-10-26 HK HK14113013.0A patent/HK1199405A1/xx unknown
- 2012-10-26 KR KR1020147014125A patent/KR20140093964A/ko not_active Abandoned
- 2012-10-26 RU RU2014120694/10A patent/RU2014120694A/ru not_active Application Discontinuation
-
2014
- 2014-04-08 IL IL232017A patent/IL232017A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015502340A5 (https=) | ||
| RU2014120694A (ru) | ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА К iNKT | |
| IL274595B2 (en) | Antibodies specific to beta-tgf | |
| JP2014526898A5 (https=) | ||
| JP2013538057A5 (https=) | ||
| JP2015535828A5 (https=) | ||
| JP2018512138A5 (https=) | ||
| JP2012525829A5 (https=) | ||
| JP2017504577A5 (https=) | ||
| HRP20230844T1 (hr) | Anti-cd3 antitijela, bispecifične molekule koje vežu antigen koji veže cd3 i cd20, i njihove upotrebe | |
| RU2018112861A (ru) | Стабильные антитела, связывающиеся с несколькими антигенами | |
| JP2015511962A5 (https=) | ||
| TR201817932T4 (en) | ANTIBODIES THAT BIND STAPHYLOCOCCUS AUREUS ALPHA TOXIN SPECIFICALLY AND METHODS OF USE | |
| RU2015136078A (ru) | Антитело против с5 и способ предупреждения и лечения обусловленных комплементом заболеваний | |
| JP2017505125A5 (https=) | ||
| RU2016100892A (ru) | Антитела против tweakr и их применение | |
| JP2018510617A5 (https=) | ||
| JP2018502060A5 (https=) | ||
| JP2017531427A5 (https=) | ||
| JP2015514110A5 (https=) | ||
| JP2009225799A5 (https=) | ||
| HK1207655A1 (en) | Affinity matured anti-ccr4 humanized monoclonal antibodies and methods of use | |
| MX2009011996A (es) | Anticuerpos anti-coestimulador inducible y su uso en el tratamiento de oncologia, transplante y enfermedad autoinmunologica. | |
| CN113710229A (zh) | 用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物 | |
| HRP20191334T1 (hr) | Anti-fcrn antitijela |